CA Stock MarketDetailed Quotes

Vaxil Bio Ltd (VXL)

Watchlist
  • 0.265
  • 0.0000.00%
15min DelayMarket Closed May 15 16:00 ET
1.06MMarket Cap1.44P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vaxil Bio Ltd (VXL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.96%-158K
46.55%-31K
34.88%-28K
22.39%-52K
-135.00%-47K
66.49%-188K
15.94%-58K
12.24%-43K
75.99%-67K
87.80%-20K
Net income from continuing operations
500.77%521K
--567K
44.44%-20K
222.22%44K
-20.69%-70K
48.82%-130K
--0
-28.57%-36K
71.65%-36K
53.60%-58K
Unrealized gains and losses of investment securities
---613K
----
----
----
----
----
----
----
----
----
Remuneration paid in stock
--0
--0
--0
--0
--0
-75.00%5K
--0
--0
0.00%2K
-25.00%3K
Other non cashItems
-288.89%-70K
290.00%19K
---12K
---73K
---4K
---18K
---10K
----
----
----
Change In working capital
108.89%4K
91.67%-4K
300.00%4K
30.30%-23K
-22.86%27K
86.24%-45K
52.48%-48K
103.45%1K
78.57%-33K
181.40%35K
-Change in receivables
-61.54%5K
-533.33%-13K
275.00%7K
163.64%7K
-84.00%4K
285.71%13K
-25.00%3K
-125.00%-4K
71.05%-11K
127.27%25K
-Change in payables and accrued expense
98.28%-1K
117.65%9K
-160.00%-3K
-36.36%-30K
130.00%23K
81.88%-58K
51.43%-51K
111.11%5K
81.03%-22K
118.52%10K
Cash from discontinued investing activities
Operating cash flow
15.96%-158K
46.55%-31K
34.88%-28K
22.39%-52K
-135.00%-47K
66.49%-188K
15.94%-58K
12.24%-43K
75.99%-67K
87.80%-20K
Investing cash flow
Cash flow from continuing investing activities
206.40%266K
139K
127K
-250K
0
0
Net other investing changes
206.40%266K
--139K
----
----
----
---250K
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
206.40%266K
--139K
--127K
----
----
---250K
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
127K
0
Net common stock issuance
--127K
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--127K
----
----
----
----
--0
----
----
----
----
Net cash flow
Beginning cash position
-52.24%448K
-16.45%447K
-41.09%347K
-56.20%403K
-52.24%448K
-37.88%938K
-46.98%535K
-44.64%589K
-31.45%920K
-37.88%938K
Current changes in cash
145.51%223K
367.86%225K
276.79%99K
83.64%-54K
-135.00%-47K
12.66%-490K
-21.74%-84K
-14.29%-56K
-18.28%-330K
87.80%-20K
Effect of exchange rate changes
----
----
-50.00%1K
-100.00%-2K
0.00%2K
--0
-50.00%-3K
133.33%2K
-200.00%-1K
150.00%2K
End cash Position
49.78%671K
49.78%671K
-16.45%447K
-41.09%347K
-56.20%403K
-52.24%448K
-52.24%448K
-46.98%535K
-44.64%589K
-31.45%920K
Free cash from
15.96%-158K
46.55%-31K
34.88%-28K
22.39%-52K
-135.00%-47K
66.49%-188K
15.94%-58K
12.24%-43K
75.99%-67K
87.80%-20K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.96%-158K46.55%-31K34.88%-28K22.39%-52K-135.00%-47K66.49%-188K15.94%-58K12.24%-43K75.99%-67K87.80%-20K
Net income from continuing operations 500.77%521K--567K44.44%-20K222.22%44K-20.69%-70K48.82%-130K--0-28.57%-36K71.65%-36K53.60%-58K
Unrealized gains and losses of investment securities ---613K------------------------------------
Remuneration paid in stock --0--0--0--0--0-75.00%5K--0--00.00%2K-25.00%3K
Other non cashItems -288.89%-70K290.00%19K---12K---73K---4K---18K---10K------------
Change In working capital 108.89%4K91.67%-4K300.00%4K30.30%-23K-22.86%27K86.24%-45K52.48%-48K103.45%1K78.57%-33K181.40%35K
-Change in receivables -61.54%5K-533.33%-13K275.00%7K163.64%7K-84.00%4K285.71%13K-25.00%3K-125.00%-4K71.05%-11K127.27%25K
-Change in payables and accrued expense 98.28%-1K117.65%9K-160.00%-3K-36.36%-30K130.00%23K81.88%-58K51.43%-51K111.11%5K81.03%-22K118.52%10K
Cash from discontinued investing activities
Operating cash flow 15.96%-158K46.55%-31K34.88%-28K22.39%-52K-135.00%-47K66.49%-188K15.94%-58K12.24%-43K75.99%-67K87.80%-20K
Investing cash flow
Cash flow from continuing investing activities 206.40%266K139K127K-250K00
Net other investing changes 206.40%266K--139K---------------250K--0--0--------
Cash from discontinued investing activities
Investing cash flow 206.40%266K--139K--127K-----------250K--0--0--------
Financing cash flow
Cash flow from continuing financing activities 127K0
Net common stock issuance --127K------------------0----------------
Cash from discontinued financing activities
Financing cash flow --127K------------------0----------------
Net cash flow
Beginning cash position -52.24%448K-16.45%447K-41.09%347K-56.20%403K-52.24%448K-37.88%938K-46.98%535K-44.64%589K-31.45%920K-37.88%938K
Current changes in cash 145.51%223K367.86%225K276.79%99K83.64%-54K-135.00%-47K12.66%-490K-21.74%-84K-14.29%-56K-18.28%-330K87.80%-20K
Effect of exchange rate changes ---------50.00%1K-100.00%-2K0.00%2K--0-50.00%-3K133.33%2K-200.00%-1K150.00%2K
End cash Position 49.78%671K49.78%671K-16.45%447K-41.09%347K-56.20%403K-52.24%448K-52.24%448K-46.98%535K-44.64%589K-31.45%920K
Free cash from 15.96%-158K46.55%-31K34.88%-28K22.39%-52K-135.00%-47K66.49%-188K15.94%-58K12.24%-43K75.99%-67K87.80%-20K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -